Residency · Residency · Otolaryngology
Wound Healing and Scar Management in the Head and Neck
Introduction
Wound healing in the head and neck region is of particular importance due to the cosmetic and functional demands of this area. The rich blood supply of the face promotes excellent healing but also creates unique challenges. Understanding the biology of wound healing, factors that impair healing, and evidence-based strategies for scar optimization is essential for every otolaryngologist and facial plastic surgeon.
Phases of Wound Healing
Phase 1: Hemostasis and Inflammation (Days 0-5)
Hemostasis: platelet aggregation, fibrin clot formation, vasoconstriction. Inflammation: neutrophils arrive within hours (bacterial clearance); monocytes/macrophages arrive at 48-72 hours and orchestrate the transition to proliferation. Macrophages are the most critical cell in wound healing — depletion severely impairs repair. Cytokines: TNF-alpha, IL-1, IL-6, PDGF, TGF-beta.
Phase 2: Proliferation (Days 5-21)
Angiogenesis: new blood vessel formation driven by VEGF and FGF. Fibroplasia: fibroblasts migrate into the wound and deposit type III collagen. Granulation tissue formation: new capillaries + fibroblasts + extracellular matrix. Epithelialization: keratinocytes migrate from wound edges and adnexal structures (hair follicles, sweat glands) to cover the wound surface. Wound contraction: myofibroblasts (alpha-smooth muscle actin) contract the wound edges together.
Phase 3: Remodeling (Day 21 to 1-2 Years)
Type III collagen is replaced by type I collagen (stronger, more organized). Collagen cross-linking and fiber realignment along lines of stress. Maximum tensile strength reached at approximately 6-8 weeks: 80% of original strength (never returns to 100%). Balance between collagen synthesis (fibroblasts) and collagen degradation (matrix metalloproteinases). Scar maturation: initially red, raised, and firm; gradually becomes pale, flat, and soft over 12-18 months.
Factors Affecting Wound Healing
Local Factors
Blood supply: the head and neck has excellent vascularity (heals faster and tolerates higher bacterial loads than other body regions). Infection: bacterial load >10^5 organisms/gram of tissue impairs healing. Foreign bodies: sutures, debris, devitalized tissue. Radiation: impairs fibroblast function, angiogenesis, and collagen synthesis. Wound tension: excessive tension leads to widened scars. Wound orientation: scars parallel to relaxed skin tension lines (RSTLs) heal with less visible scarring.
Systemic Factors
Nutrition: protein, vitamin C (essential for collagen hydroxylation), vitamin A, zinc. Diabetes mellitus: impairs all phases of healing; hyperglycemia reduces neutrophil function and angiogenesis. Smoking: nicotine causes vasoconstriction and reduces tissue oxygenation; increases flap necrosis risk 3-6 fold. Immunosuppression: corticosteroids inhibit inflammation and collagen synthesis. Medications: anticoagulants (hematoma risk), bevacizumab (anti-VEGF, impairs angiogenesis). Age: slower healing in elderly due to reduced growth factor production and collagen deposition.
Types of Wound Closure
Primary Intention (First Intention)
Surgical closure of a clean wound with sutures, staples, or adhesives. Minimal scar formation; fastest healing, Standard for most elective surgical incisions.
Secondary Intention
Wound left open to heal by granulation, contraction, and epithelialization. Used for infected wounds, large tissue deficits, or when closure would cause unacceptable tension. Concave surfaces of the face (medial canthus, temple, alar crease) heal well by secondary intention.
Delayed Primary Closure (Third Intention)
Wound initially left open (for debridement, infection control), then closed surgically after 3-5 days. Combines advantages of secondary (infection control) and primary (cosmetic result) healing.
Scar Management
Prevention
Tension-free closure: layered closure with buried dermal sutures to reduce epidermal tension. Incision planning: orient incisions along RSTLs and natural skin creases when possible. Meticulous technique: evert wound edges, avoid crushing tissue, use fine suture material. Early suture removal to prevent railroad tracking (face: 5-7 days). Sun protection: UV exposure causes hyperpigmentation of new scars; recommend SPF 30+ for 6-12 months.
Conservative Scar Treatments
Silicone sheeting and silicone gel: first-line for hypertrophic scars and keloid prevention; mechanism: hydration and occlusion; recommended for 12-24 hours/day for 3-6 months. Pressure therapy: for hypertrophic scars; continuous pressure garments. Massage: scar massage starting at 2-3 weeks post-surgery; softens scars and promotes collagen remodeling. Sunscreen: protect immature scars from UV-induced hyperpigmentation.
Intralesional Corticosteroid Injection
Triamcinolone acetonide (Kenalog): 10-40 mg/mL injected directly into hypertrophic scars or keloids. Mechanism: inhibits fibroblast proliferation and collagen synthesis; promotes collagen degradation. Repeat injections every 4-6 weeks; risk of skin atrophy, telangiectasia, hypopigmentation. Most effective when combined with other modalities.
Surgical Scar Revision
Wait 12-18 months for scar maturation before considering revision. Techniques: Excision and re-closure: narrow the scar with tension-free layered closure. Z-plasty: breaks up a linear scar, reorients it along RSTLs, and lengthens a contracted scar. W-plasty: irregularizes a scar so it is less conspicuous. Geometric broken line closure (GBLC): irregular interdigitating flaps to camouflage the scar. Serial excision: for wide scars; excise a portion and close, repeat after healing. Tissue expansion: recruit adjacent tissue for coverage of large defects.
Laser and Energy-Based Treatments
Pulsed dye laser (PDL, 595 nm): targets hemoglobin in immature red scars; reduces erythema and may flatten hypertrophic scars. Fractional CO2 laser: creates microscopic columns of thermal injury to stimulate collagen remodeling; improves texture, thickness, and pliability of scars. Fractional erbium laser: similar mechanism with less thermal injury.
Pathologic Scarring
| Feature | Hypertrophic Scar | Keloid |
|---|---|---|
| Extent | Confined to wound boundaries | Extends beyond wound margins |
| Timing | Weeks to months post-injury | Months to years |
| Natural history | Often improves spontaneously (12-24 months) | Does not regress; may grow |
| Skin type association | Any | More common in darker skin tones |
| Common locations | Areas of tension | Earlobes, chest, shoulders |
| Recurrence after excision | Low | High (50-80%) without adjuvant therapy |
| Treatment | Silicone, steroids, laser | Excision + steroids/radiation/5-FU |
Hypertrophic Scars
Raised, red, firm scars confined to the wound boundaries. Occur within weeks to months of surgery, Often improve spontaneously over 12-24 months. Treatment: silicone, compression, intralesional steroids, laser.
Keloids
Scar tissue that extends beyond the original wound margins. More common in individuals with darker skin tones. Common locations: earlobes, chest, shoulders. High recurrence rate after excision alone (50-80%). Treatment: excision + adjuvant therapy (intralesional steroids, radiation, pressure earrings for earlobe keloids). 5-FU injection: intralesional 5-fluorouracil alone or combined with steroids; inhibits fibroblast proliferation.
Contracture
Wound contraction causing functional limitation (e.g., ectropion, microstomia, neck contracture). More common in burns and wounds healing by secondary intention. Treatment: scar release with local flaps, Z-plasties, skin grafts, or free tissue transfer.
Key Clinical Pearls
The head and neck has the best blood supply of any body region, allowing successful closure of wounds that would fail elsewhere. Smoking cessation at least 4 weeks before and after surgery is the single most impactful modifiable factor for wound healing. Scars take 12-18 months to mature — avoid early scar revision unless functional impairment exists. Silicone sheeting is the best evidence-based first-line treatment for hypertrophic scar prevention. Incisions placed along relaxed skin tension lines heal with the least conspicuous scars. Keloid excision without adjuvant therapy has an unacceptable recurrence rate; always combine with steroids, radiation, or other modalities. Tensile strength of a healed wound never exceeds 80% of the original unwounded tissue.
References
- Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314-321.
- Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg. 2017;43(Suppl 1):S3-S18.
- Thomas JR, Prendiville S. Update in scar revision. Facial Plast Surg Clin North Am. 2019;27(4):411-417.
- Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560-571.